Aaron Domack, MD | |
661 E Altamonte Dr Ste 325, Altamonte Springs, FL 32701-5103 | |
(407) 821-3530 | |
Not Available |
Full Name | Aaron Domack |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 7 Years |
Location | 661 E Altamonte Dr Ste 325, Altamonte Springs, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225569213 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 35.144870 (Ohio) | Secondary |
207Y00000X | Otolaryngology | ME162491 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Adventhealth Orlando | Orlando, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Florida Hospital Medical Group Inc | 0749186153 | 1163 |
News Archive
In a new study published on the preprint server medRxiv, a team of researchers on behalf of the Imperial College London COVID-19 Response Team used longitudinal and age-specific population mobility and COVID-19 mortality data to model and predict SARS-CoV-2 spread in the US.
Immunome, a discovery-stage antibody platform company focused on life-threatening infectious diseases, announced today the completion of a financing by BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania. The funding round also included private investors.
Engineers are unlikely to tinker with the cooling system if they want to increase the size of an engine. Yet chemists at the Max Planck Institute for Coal Research have adopted an approach similar to this in their efforts to optimise an enzyme for practical applications. They
Oncolytics Biotech Inc. today announced that enrollment has been completed in a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer (IND 210). The trial is being sponsored and conducted by the NCIC Clinical Trials Group at Queen's University in Kingston, Ontario.
› Verified 7 days ago
Entity Name | Florida Hospital Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225034234 PECOS PAC ID: 0749186153 Enrollment ID: O20031208000807 |
News Archive
In a new study published on the preprint server medRxiv, a team of researchers on behalf of the Imperial College London COVID-19 Response Team used longitudinal and age-specific population mobility and COVID-19 mortality data to model and predict SARS-CoV-2 spread in the US.
Immunome, a discovery-stage antibody platform company focused on life-threatening infectious diseases, announced today the completion of a financing by BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania. The funding round also included private investors.
Engineers are unlikely to tinker with the cooling system if they want to increase the size of an engine. Yet chemists at the Max Planck Institute for Coal Research have adopted an approach similar to this in their efforts to optimise an enzyme for practical applications. They
Oncolytics Biotech Inc. today announced that enrollment has been completed in a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer (IND 210). The trial is being sponsored and conducted by the NCIC Clinical Trials Group at Queen's University in Kingston, Ontario.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Aaron Domack, MD 661 E Altamonte Dr Ste 325, Altamonte Springs, FL 32701-5103 Ph: (407) 821-3530 | Aaron Domack, MD 661 E Altamonte Dr Ste 325, Altamonte Springs, FL 32701-5103 Ph: (407) 821-3530 |
News Archive
In a new study published on the preprint server medRxiv, a team of researchers on behalf of the Imperial College London COVID-19 Response Team used longitudinal and age-specific population mobility and COVID-19 mortality data to model and predict SARS-CoV-2 spread in the US.
Immunome, a discovery-stage antibody platform company focused on life-threatening infectious diseases, announced today the completion of a financing by BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania. The funding round also included private investors.
Engineers are unlikely to tinker with the cooling system if they want to increase the size of an engine. Yet chemists at the Max Planck Institute for Coal Research have adopted an approach similar to this in their efforts to optimise an enzyme for practical applications. They
Oncolytics Biotech Inc. today announced that enrollment has been completed in a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer (IND 210). The trial is being sponsored and conducted by the NCIC Clinical Trials Group at Queen's University in Kingston, Ontario.
› Verified 7 days ago